The Keap1-KD-mediated activation of this pathway reportedly reduces weight gain and improves insulin resistance in the short term (8–9 weeks) in HFD-fed mice; however, it conversely causes weight gain and the development of insulin resistance in the long-term in HFD-fed mice35. Here, KEAP1 is linked to Insulin resistance.